Prevalence of atherosclerotic cardiovascular disease and subsequent major adverse cardiovascular events in <scp>Alberta, Canada</scp>: A real‐world evidence study
Prevalence of atherosclerotic cardiovascular disease and subsequent major adverse cardiovascular events in <scp>Alberta, Canada</scp>: A real‐world evidence study is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Prevalence of atherosclerotic cardiovascular disease and subsequent major adverse cardiovascular events in <scp>Alberta, Canada</scp>: A real‐world evidence study have?
Prevalence of atherosclerotic cardiovascular disease and subsequent major adverse cardiovascular events in <scp>Alberta, Canada</scp>: A real‐world evidence study has 32 citations in the OpenAlex counts ScholarIQ stores.
When was Prevalence of atherosclerotic cardiovascular disease and subsequent major adverse cardiovascular events in <scp>Alberta, Canada</scp>: A real‐world evidence study published?
Prevalence of atherosclerotic cardiovascular disease and subsequent major adverse cardiovascular events in <scp>Alberta, Canada</scp>: A real‐world evidence study has 2021 year in the ScholarIQ index.
What is the open-access status of Prevalence of atherosclerotic cardiovascular disease and subsequent major adverse cardiovascular events in <scp>Alberta, Canada</scp>: A real‐world evidence study?
Prevalence of atherosclerotic cardiovascular disease and subsequent major adverse cardiovascular events in <scp>Alberta, Canada</scp>: A real‐world evidence study has gold oa status in the ScholarIQ index.
What is the DOI of Prevalence of atherosclerotic cardiovascular disease and subsequent major adverse cardiovascular events in <scp>Alberta, Canada</scp>: A real‐world evidence study?
The DOI for Prevalence of atherosclerotic cardiovascular disease and subsequent major adverse cardiovascular events in <scp>Alberta, Canada</scp>: A real‐world evidence study is on the source record.
What is the PMID of Prevalence of atherosclerotic cardiovascular disease and subsequent major adverse cardiovascular events in <scp>Alberta, Canada</scp>: A real‐world evidence study?
The PMID for Prevalence of atherosclerotic cardiovascular disease and subsequent major adverse cardiovascular events in <scp>Alberta, Canada</scp>: A real‐world evidence study is on the source record.
What is the OpenAlex record for Prevalence of atherosclerotic cardiovascular disease and subsequent major adverse cardiovascular events in <scp>Alberta, Canada</scp>: A real‐world evidence study?
The OpenAlex for Prevalence of atherosclerotic cardiovascular disease and subsequent major adverse cardiovascular events in <scp>Alberta, Canada</scp>: A real‐world evidence study is on the source record.